Header Logo

Connection

Matthew Meriggioli to Cholinesterase Inhibitors

Back to Details
This is a "connection" page, showing publications Matthew Meriggioli has written about Cholinesterase Inhibitors.
Matthew Meriggioli
Connection Strength
0.188
Cholinesterase Inhibitors
  1. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009 May; 8(5):475-90.
    View in: PubMed
    Score: 0.081
  2. Advances in the diagnosis of neuromuscular junction disorders. Am J Phys Med Rehabil. 2005 Aug; 84(8):627-38.
    View in: PubMed
    Score: 0.062
  3. Myasthenia gravis. Clin Neuropharmacol. 2000 Nov-Dec; 23(6):291-5.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.